Last reviewed · How we verify

Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents

NCT03894696 UNKNOWN

The primary objective of this study is to prospectively analyse psychiatric outcomes, specifically depression and anxiety in patients with hepatitis C virus infection who are initiated on DAA therapy (sofosbuvir based regimen).

Details

Lead sponsorAssiut University
StatusUNKNOWN
Enrolment200
Start dateThu Aug 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri May 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions